4527 JPX Week ended 07 Aug 2026

Weekly Investor Report

Rohto Pharmaceutical Co.,Ltd. · Consumer Defensive · Household & Personal Products

Open interactive chart View report data
Latest close 2,862 JPY
19.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 17.5% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 19.8%, after a 17.8% four-week move. The latest news-sentiment score is 58/100. Near-term considerations: price is close to its 52-week high.

Setup score 66 out of 100
Latest Close 2,862 JPY 7 Aug 2026
1W Return 19.8% latest completed week
4W Return 17.8% short-term follow-through
12W Return 17.4% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 3.4x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 19.8% Latest completed week; four-week move 17.8%. Indicator stack 26/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 58/100 6 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 17.5% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 19.8%, after a 17.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 3.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1912-week average 0.20

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 17.8% over four weeks, 17.4% over 12 weeks, and 16.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W19.8%
4W17.8%
12W17.4%
26W12.8%
52W16.7%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.78Latest activity-pressure read.
Pressure change7107.7%Four-week change in activity pressure.
Leadership-4.02Latest relative-leadership reading.
RS change83.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment58/100

Weighted news tone is positive across 6 relevant articles.

2 positive · 4 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown0.0%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+19.8%Week of 7 Aug.
Worst week-6.6%Week of 6 Mar.
Latest week+19.8%Week of 7 Aug.

Shape of recent returns

Strong gains3
Modest gains12
Flat weeks0
Modest losses7
Sharp losses4
Recent vol6.0%13-week weekly-return volatility.
Base vol3.9%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis24/100

Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.19; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment58/100

Weighted news tone is positive across 6 relevant articles.

Rohto Pharmaceutical Co.,Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20262,862 JPY19.8%2,437 JPY2,719 JPY0.78-4.0213.2MOff
31 Jul 20262,388 JPY1.6%2,426 JPY2,724 JPY0.46-18.886.9MOff
24 Jul 20262,350 JPY-5.1%2,433 JPY2,727 JPY0.30-21.003.5MOff
17 Jul 20262,478 JPY2.0%2,443 JPY2,730 JPY0.29-16.584.5MOff
10 Jul 20262,430 JPY1.0%2,445 JPY2,733 JPY-0.01-23.844.7MOff
3 Jul 20262,406 JPY0.4%2,446 JPY2,736 JPY-0.23-26.37762.6KOff
26 Jun 20262,397 JPY1.1%2,447 JPY2,740 JPY-0.21-26.72885.4KOff
19 Jun 20262,370 JPY2.0%2,450 JPY2,745 JPY-0.07-29.901.6MOff
12 Jun 20262,324 JPY-3.2%2,456 JPY2,750 JPY0.22-26.39801.5KOff
5 Jun 20262,400 JPY0.8%2,459 JPY2,755 JPY0.35-25.17832.8KOff
29 May 20262,381 JPY-6.2%2,458 JPY2,759 JPY0.15-25.934.5MOff
22 May 20262,538 JPY4.1%2,458 JPY2,763 JPY-0.21-17.854.2MOff
15 May 20262,438 JPY3.0%2,454 JPY2,765 JPY-0.65-19.054.8MOff
8 May 20262,366 JPY0.4%2,454 JPY2,769 JPY-0.94-23.542.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context